Samei Huda reviews a recent study of schizophrenia and subsequent urban deprivation, which revisits the social drift hypothesis.
[read the full story...]
Raphael Underwood reports on the findings of a recent RCT of group body psychotherapy for negative symptoms of schizophrenia, which finds that body psychotherapy did not have a clinically beneficial effect on reducing emotional withdrawal or improving social functioning.
[read the full story...]
Marcus Munafo considers the implications of a recent Swedish population study, which explores patterns of non-random mating within and across 11 major psychiatric disorders.
[read the full story...]
Mandy Johnstone writes her debut Mental Elf blog on a recent Nature study, which identifies a set of genetic variations that are strongly associated with the risk of developing schizophrenia.
[read the full story...]
Tracey Roberts summarises a recent RCT of the efficacy and safety of paliperidone palmitate 3-month formulation for patients with schizophrenia.
[read the full story...]
Andrew Jones reports on a recent systematic review and network meta-analysis of the efficacy and tolerability of pharmacotherapy for smoking cessation in severe mental illness, which finds a promising but low quality result for bupropion and varenicline.
[read the full story...]
Joanne Wallace considers a recent health technology assessment on the risks and benefits of psychotropic medication in pregnancy, which supports previous associations between valproate and adverse child outcomes.
[read the full story...]
Alan Underwood highlights a new meta-analysis, which suggests that people with mental health problems can benefit if they are prompted to form if-then plans, which specify when, where and how they will achieve their goals.
[read the full story...]
Murtada Alsaif summarises a recent network meta-analysis, which looks at the efficacy, acceptability and tolerability of antipsychotics for treatment-resistant schizophrenia.
[read the full story...]
Suzanne Dash considers the findings of a promising new small randomised controlled trial, which aims to reduce delusional conviction in people with schizophrenia who experience persecutory delusions.
[read the full story...]
